Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma

NCT02050919 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Pleomorphic Rhabdomyosarcoma
Stage IIB Adult Soft Tissue Sarcoma AJCC v7
Stage III Adult Soft Tissue Sarcoma AJCC v7
Stage IV Adult Soft Tissue Sarcoma AJCC v7

Interventions

DRUG: Epirubicin Hydrochloride
RADIATION: External Beam Radiation Therapy
DRUG: Ifosfamide
OTHER: Laboratory Biomarker Analysis
DRUG: Sorafenib Tosylate
PROCEDURE: Therapeutic Conventional Surgery

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]
[object Object]